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Objective: To assess the performance of the Acute Physiology and
Chronic Health Evaluation II (APACHE II) mortality prediction model
in pregnant and recently pregnant women receiving critical care in
low-, middle-, and high-income countries during the study period
(1985e2015), using a structured literature review.
Data sources: Ovid MEDLINE, Embase, Web of Science, and
Evidence-Based Medicine Reviews, searched for articles published
between 1985 and 2015.
Study selection: Twenty-ﬁve studies (24 publications), of which two
were prospective, were included in the analyses. Ten studies were
from high-income countries (HICs), and 15 were from low- and
middle-income countries (LMICs). Median study duration and size
were six years and 124 women, respectively.
Data synthesis: ICU admission complicates 0.48% of deliveries, and
pregnant and recently pregnant women account for 1.49% of ICU
admissions. One quarter were admitted while pregnant, three
quarters of these for an obstetric indication and for a median of three
days. The median APACHE II score was 10.9, with a median
APACHE II-predicted mortality of 16.6%. Observed mortality was
4.6%, and the median standardized mortality ratio was 0.36
(interquartile range 0.23 to 0.73). The standardized mortality ratio
was < 0.9 in 24 of 25 studies. Women in HICs were more frequentlyKey Words: Acute Physiology and Chronic Health Evaluation II,
critical care, pregnancy, maternal mortality, structured review
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http://dx.doi.org/10.1016/j.jogc.2016.06.013admitted with a medical comorbidity but were less likely to die than
were women in LMICs.
Conclusion: The APACHE II score consistently overestimates
mortality risks for pregnant and recently pregnant women receiving
critical care, whether they reside in HICs or LMICs. There is a need
for a pregnancy-speciﬁc outcome prediction model for these
women.
Résumé
Objectif : Évaluer l’efﬁcacité du score de prédiction de la mortalité
APACHE II (Acute Physiology and Chronic Health Evaluation II)
chez les femmes enceintes ou l’ayant été récemment admises aux
soins intensifs dans des pays à faible revenu, à revenu
intermédiaire et à revenu élevé pendant la période à l’étude
(1985e2015), au moyen d’une revue de la littérature structurée.
Sources de données : MEDLINE (interface Ovid), Embase, Web of
Science et Evidence-Based Medicine Reviews; recherche d’articles
publiés entre 1985 et 2015.
Sélection des études : Vingt-cinq études (24 publications), dont deux
à visée prospective, ont été retenues pour l’analyse. Dix avaient été
menées dans des pays à revenu élevé et quinze dans des pays à
revenu faible ou intermédiaire. La durée médiane était de six ans, et
le nombre de sujets médian, de 124 femmes.
Synthèse des données : Environ 0,48 % des accouchements sont
compliqués par une admission aux soins intensifs, et les femmes
enceintes ou l’ayant été récemment représentent 1,49 % des
admissions aux soins intensifs. Le quart des patientes visées par
l’étude avaient été admises pendant la grossesse, les trois quarts
de ces dernières pour une indication obstétricale et pour une durée
d’hospitalisation médiane de trois jours. Le score APACHE II
médian était de 10,9, de sorte que l’outil prédisait un taux de
mortalité médian de 16,6 %. Le taux de mortalité mesuré a été de
4,6 %, et le ratio standardisé de mortalité médian, de 0,36 (intervalle- JOGC - 2016 l 1
OBSTETRICSinterquartile de 0,23 à 0,73). Ce ratio était inférieur à 0,9 dans 24
des 25 études examinées. Les femmes des pays à revenu élevé
étaient plus souvent hospitalisées pour un problème comorbide,
mais étaient moins susceptibles de mourir que celles des pays à
revenu faible et intermédiaire.
Conclusion : Le score APACHE II surestime systématiquement le
risque de mortalité des femmes enceintes ou l’ayant été récemment
qui reçoivent des soins intensifs, qu’elles habitent un pays à revenu
élevé ou un pays à revenu faible ou intermédiaire. Il est donc
nécessaire de trouver un modèle de prédiction des résultats propres
à la grossesse pour cette population.
Copyright ª 2016 The Authors. Published by Elsevier Inc. on behalf of
The Society of Obstetricians and Gynaecologists of Canada/La Société
des obstétriciens et gynécologues du Canada. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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n high-income countries, most maternal deaths occurIpostpartum and while the women are receiving critical
care in an ICU.1 In low- and middle-income countries,
where prenatal surveillance is more often opportunistic, the
burden of mortality is greater and critical care is often
unavailable; deaths in LMICs are more evenly spread be-
tween the prenatal, intrapartum, and postpartum periods,
and approximately 50% occur before admission to a health
facility.2,3
The Acute Physiology and Chronic Health Evaluation II
score4 is the most widely used and most studied of
the critical care outcome prediction models in obstetric
patients and has been assessed in both HTCs and LMICs.
With conﬂicting evidence from a large number of obser-
vational studies on the clinical utility and applicability of the
APACHE II score, we sought to assess its accuracy as a
critical care prediction model in obstetric patients through
formal literature review. The objective of this review was to
assess the performance of the APACHE II mortality pre-
diction model in pregnant and recently pregnant women
receiving critical care.ABBREVIATIONS
APACHE II Acute Physiology and Chronic Health Evaluation II
HICs high-income countries
IQR interquartile range
LMICs low- and middle-income countries
MWu Mann-Whitney U test
SMR standardized mortality ratio
2 l - JOGC - 2016METHODS
Literature Search
In February 2016, we carried out a formal literature search
of studies published between 1985 and 2015 using subject
headings and key words to identify all relevant literature.
The following research question was used to ﬁnalize the
search strategy: How accurate is the APACHE II critical
care model for predicting death in pregnant and post-
partum women? The search strategy used is shown in
Table 1. The search was limited to literature from 1985
onwards because use of the APACHE II score as a clinical
prediction model was ﬁrst reported in that year.4 We
searched MEDLINE (Ovid), Embase (Ovid), Web of
Science, and selected databases within Evidence-Based
Medicine Reviews (the Cochrane Central Register of
Controlled Trials, the Cochrane Methodology Register, the
Database of Abstracts of Reviews of Effects, the Health
Technology Assessment, and the National Health Service
Economic Evaluation Database). The search was not
restricted by language. We carried out the literature review
using the search terms “maternal mortality,” “maternal
death,” “clinical prediction model,” “risk prediction
model,” “ICU,” “intensive care unit,” “critical care,”
“severe maternal morbidity,” and “maternal near-miss.” In
PubMed, additional detailed searches on the topics of
maternal mortality, critical care risk prediction models,
APACHE II scoring system, severe maternal morbidity,
and maternal near-miss were performed. We searched
bibliographies and citations to identify secondary readings.
Initially, all mortality prediction models were included in
the search; for meaningful comparison, this was then
reﬁned to include the APACHE II model only.
We excluded studies not relating to maternal mortality,
studies not containing details of APACHE II scores in the
population, studies relating to one speciﬁc type of
complication only (e.g., solely eclampsia), and studies
limited to perinatal mortality.Data Analysis
For each study, data were manually extracted by two of
three reviewers (HMR, SS, PvD) and entered into an Excel
database that included information related to study char-
acteristics (design, population, and setting), incidence of
maternal ICU admissions, and reported outcomes.
Analyses were performed using Prism 6.05 (GraphPad
Software Inc., La Jolla, CA). Because most data were not
normally distributed (determined by D’Agostino-Pearson
normality test), continuous data are presented as medians
(interquartile range) for consistency. Median APACHE II
scores and predicted and observed mortality were
Table 1. Literature search strategy
Sets Ovid MEDLINE Embase Web of Science EBMR
A exp Decision Support Techniques/
exp Forecasting/(Decision* or
Model* or Predict* or rule*).mp.
exp “prediction and forecasting”/
exp medical decision
making/exp decision support
system/(Decision* or Model* or
Predict* or rule*).mp.
TOPIC:(Decision* or Model* or
Predict* or rule* OR
forecast*)
exp Decision Support Techniques/
exp Forecasting/(Decision* or
Model* or Predict* or rule*).mp.
B exp Puerperal Disorders/exp
Perinatal Care/exp Pregnancy/
exp Pregnancy Complications/
exp Postpartum Period/exp
Peripartum Period/exp
Pregnancy Trimesters/exp
Puerperium/exp Delivery,
Obstetric/exp Abortion,
Induced/(abortion* or
antepartum or prepartum or
intrapartum or postpartum or
puerper* or obstetric* or gestat*
or pregnant or pregnanc*).mp.
exp perinatal care/exp pregnancy
disorder/exp postnatal care/exp
pregnancy/exp perinatal period/
exp obstetric procedure/exp
induced abortion/puerperal
disorder/exp maternal disease/
(abortion* or antepartum or
prepartum or intrapartum
or postpartum or puerper*
or obstetric* or gestat* or
pregnant or pregnanc*).mp
TOPIC:(abortion* or
antepartum or prepartum or
intrapartum
or postpartum or puerper*
or obstetric* or gestat* or
pregnant or pregnanc*
or perinatal* or postpart*
or maternal* or maternit*)
exp Puerperal Disorders/exp
Perinatal Care/exp Pregnancy/
exp Pregnancy Complications/
exp Postpartum Period/exp
Peripartum Period/exp
Pregnancy Trimesters/exp
Puerperium/exp Delivery,
Obstetric/exp Abortion,
Induced/(abortion* or
antepartum or prepartum
or intrapartum or postpartum or
puerper* or obstetric* or gestat*
or pregnant or pregnanc* or
perinatal* or postpart* or
maternal* or intensive*).mp.
C exp Critical Illness/exp Life
Support Care/exp Intensive
Care Units/exp Critical Care/
(critical care or intensive care
or icu).mp.
exp critical illness/exp intensive
care/exp intensive care unit/exp
critically ill patient/(critical care
or intensive care or icu or close
support).mp.
TOPIC:(critical* OR intensiv*
OR ICU or “close support”
or “life support”)
exp Critical Illness/exp Life
Support Care/exp Intensive
Care Units/exp Critical Care/
(critical* or intensive* or ICU or
“close support”).mp.
D exp Maternal Mortality/exp
Mortality/exp Morbidity/mo.fs.
exp survival analysis/exp survival/
exp Maternal Death/exp Life
Expectancy/exp Longevity/exp
mortality/exp morbidity/exp
survival analysis/exp survival/
exp Treatment Failure/(death*
or mortal* or morbid* or
surviv*).mp.
exp Mortality/exp Morbidity/exp
survival analysis/exp survival/
exp treatment failure/(death* or
mortal* or morbid* or
surviv*).mp.
TOPIC:(death* or mortal* or
morbid* or surviv*)
exp Maternal Mortality/exp
Mortality/exp Morbidity/mo.fs.
exp survival analysis/exp survival/
exp Maternal Death/exp Life
Expectancy/exp Longevity/exp
Treatment Failure/(death* or
mortal* or morbid* or
surviv*).mp.
limit A and B and C and D to
yr¼“1985e2015”
limit A and B and C and D to
yr¼“1985e2015”
limit A and B and C and D to
yr¼“1985e2015”
limit A and B and C and D to
yr¼“1985e2015”
The Usefulness of the APACHE II Score in Obstetric Critical Care: A Structured Reviewcompared, and standardized mortality ratios (observed/
predicted maternal deaths) were calculated where possible.
Studies were divided between those in HICs and in LMICs.
Because all of the included studies were cohort studies, no
estimation of bias was undertaken. Differences between
continuous variables in HIC and LMIC groups were
analyzed using the Mann-Whitney U test. P < 0.05 was
considered statistically signiﬁcant for all analyses.RESULTS
Study Selection
We identiﬁed 4519 abstracts meeting the search criteria,
and these were screened based on the title and abstract.
Eighty-seven studies met the eligibility criteria, and the
corresponding full text articles were reviewed; those notcontaining details related to APACHE II were excluded.
Twenty-four studies were suitable for inclusion in the
detailed literature review and data abstraction.5e28 Of
these, one contained data from two separate countries (the
United States and India), and these were divided and
assessed as two separate sites.22 An additional study
duplicated the relevant data of another study and was
excluded from the analysis.29 Therefore, 25 studies were
included in the review (Table 2).STUDY SETTING, POPULATION, AND DESIGN
Twenty-three (92%) of the studies were retrospective and
two were prospective.7,26 The median proportion of
transfers from external sites into participating ICUs was
23% (IQR 18.6% to 28.0%).- JOGC - 2016 l 3
Table 2. Overview of 25 studies included in literature review
Study
Study period
(yr) Cases (N)
First TM
(yes/no)
42 d pp
(yes/no)
Proportion of
deliveries
admitted
to ICU (%)
Maternity cases as
proportion of ICU
admissions (%)
Proportion of
maternal ICU
admissions
antepartum (%)
Obstetric indication
for maternal ICU
admission (%) ICU LOS (d)
HIC
Single site
Lapinsky et al.15 4 65 - - 0.26 - 9 71 2.9 (mean)
Afessa et al.5 7 74 - - - - 42 - 2.5 (median)
Heinonen et al.13 7 22 N N 0.09 0.14 13.6 - 5.8 (mean)
Munnur et al.22 9 174 - - 0.30 - - 68 3 (median)
Muench et al.21 2 34 - - 1.30 - 76.5 - -
Multi-site
El Solh et al.10 6 93 Y N - 0.70 62 19 -
Mahutte et al.18 6 131 N Y 0.30 - 22 - -
Hazelgrove et al.12 2 210 Y Y 0.17 1.84 19.1 73 1 (median)
Lapinsky et al.16 4 332 N N - - - 77 2 (median)
Harrison et al.11 8 1730 - - - 7.00 - 84 -
Median (IQR) (HIC) 6.0 (3.5 to 7.3) 112 (57 to 241) 0.28 (0.15 to 0.55) 1.27 (0.28 to 5.71) 22.0 (13.6 to 62.0) 72 (56 to 79) 2.7 (1.8 to 3.7)
LMIC
Single site
Lewinsohn et al.17 8 58 - - - - - - -
Tang et al.25 7 49 - - 0.12 - 12.2 80 4.1 (mean)
Cheng and Raman8 5 43 Y N 0.32 1.14 14 - 3 (median)
Demirkiran et al.9 5 125 - - 0.89 2.64 - 90 -
Mirghani et al.19 5 60 - - 0.26 2.40 - - 1.6 (mean)
Munnur et al.22 9 754 - - 0.48 - - 68 4 (median)
Mjahed et al.20 7 364 N Y 0.62 0.15 5.5 84 5.7 (mean)
Vasquez et al.26 7 161 Y Y 0.70 0.10 36.6 74 6 (median)
Aldawood6 10 75 - - 0.15 0.75 78.6 - 2 (median)
Bhadade et al.7a 1.5 122 Y Y 4.00 - 66.39 23 -
Wang et al.28 5 101 - - 0.53 2.42 6.9 - 7.5
Paternina-Caicedo et al.23 7 726 Y Y 1.43 - 24.9 75 3 (median)
Multi-site
Karnad et al.14 4 453 Y Y 0.55 - 45.5 69 4 (median)
Rios et al.24 2 242 Y Y 0.81 3.90 - 88 2 (median)
Vasquez et al.27a 1 362 Y Y 0.69 - 24.0 82 2 (median)
Median (IQR) (LMIC) 5.5 (4.8 to 7.3) 124 (60 to 386) 0.55 (0.29 to 0.85) 1.77 (0.30 to 2.59) 24.9 (9.6 to 56.0) 78 (69 to 85) 4.0 (2.0 to 5.7)
Median (IQR) (all) 6.0 (4.0 to 7.0) 124 (61 to 310) 0.48 (0.26 to 0.81) 1.49 (0.29 to 2.59) 23.5 (12.6 to 57.9) 75 (68 to 84) 3.0 (2.0 to 4.9)
TM: trimester; pp: postpartum; LOS: length of stay.
aProspective case series, all others retrospective.
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The Usefulness of the APACHE II Score in Obstetric Critical Care: A Structured ReviewBoth the rate of ICU admission per delivery and the rate of
maternal admissions to an ICU as a proportion of total
ICU admissions varied widely between reports (Table 2).
Three quarters of maternal ICU admissions were post-
partum (Table 2).
Almost three quarters of maternal ICU admissions were
related to direct obstetric indications (Table 2). Of the
obstetric indications, the hypertensive disorders of preg-
nancy, massive obstetric hemorrhage, and sepsis were the
three most common (Table 3). Pre-existing medical
comorbidities precipitated 10.4% to 67.6% (median 30.0%
[IQR 16.1% to 37.2%]) of maternal ICU admissions. Of
the non-obstetric complications, respiratory complications
were the most common (5% to 50%; median 21% [IQR
19.7% to 59.0%]) and also included non-obstetric infec-
tious diseases/sepsis, cardiovascular, central nervous sys-
tem, and endocrine diseases (Table 3). Mechanical
ventilation rates were reported in 19 studies and ranged
from 3.3% to 74.0% (median 44.6% [IQR 19.1% to
61.5%]).
The majority of studies included women in the second and
third trimesters. Only 28% of studies (7/25) included
women from throughout pregnancy to six weeks post-
partum. Overall, 36% of studies (9/25) included women in
the ﬁrst trimester, and 36% (9/25) included women for the
full puerperium ( 42 days postpartum) (Table 2). The
duration of stay in the ICU was presented as both mean
and median durations. Mean and median durations were
combined, and an overall median of the estimates of
central tendency for duration of stay in the ICU was 3.0
days (Table 2).
Other scoring systems used were APACHE III,12
APACHE Acute Physiology Score,11 Multiple Organ
Dysfunction Syndrome,22 Mortality Prediction Model II,10
Simpliﬁed Acute Physiology Score II,10,12,16 Sequential
Organ Failure Assessment,24 and Therapeutic
Interventions Scoring System.15
Maternal Outcomes and APACHE II Results
The denominator for maternal mortality rates was the total
number of maternal ICU admissions. Maternal mortality
and perinatal rates varied widely (Table 4, Figure).
APACHE II scores were reported as both mean and
median values; the median of the estimates of central
tendency was 10.9. The receiver operating characteristic
area under the curve for the APACHE II score performed
moderately well in these studies (Table 4). However, the
median APACHE II-predicted risk of mortality was 15.7%,
and the median observed mortality rate was 4.5%, resulting
in a median standardized mortality ratio of 0.39 (IQR 0.23to 0.67) (Table 4). In all seven HIC studies and in eight of
nine LMIC studies in which the SMR could be determined,
there was substantial overestimation of maternal mortality
risk (point estimate of SMR < 0.9) (Table 4). The
y-intercept for the observed/predicted maternal mortality
regression line was 4.3 (95% CI 10.72 to 2.17) and the
slope was 0.75 (95% CI 0.41 to 1.09) (Figure).
Comparison of HIC and LMIC Results
The only measurements that differed signiﬁcantly between
the HIC- and LMIC-based studies were the median
incidence of a preexisting medical comorbidity as an
indication for admission to the ICU (HIC 44.1% [IQR
32.1% to 63.2%] vs. LMIC 18.0% [IQR 14.7% to 30.9%];
MWu P ¼ 0.013) and the median observed maternal
mortality rate (HIC 2.5% [IQR 2.3 to 4.2] vs. LMIC 7.5%
[IQR 3.5% to 17.9%]; MWu P ¼ 0.007).
DISCUSSION
Despite many publications relating to pregnant and
recently pregnant women with critical illness, few have
focused speciﬁcally on the use of mortality prediction
models. In 15 of the 16 informative studies that we iden-
tiﬁed, the APACHE II score overpredicted maternal
mortality, as the point estimate of SMR was < 0.90. Seven
of the 13 variables (54%) that are measured in the
APACHE II score (temperature, heart rate, respiratory
rate, mean arterial pressure, serum creatinine, hematocrit,
and white blood cell count) have altered physiological
ranges in pregnancy, in directions that contribute to over-
estimation of mortality risk by APACHE II.30,31
The observed overestimation of maternal mortality risk by
APACHE II was consistent between studies from HICs
and LMICs, despite the disparate risks of maternal death
between these settings. The APACHE II score did not
have improved efﬁcacy in LMICs, where mortality rates
were higher, still overpredicting mortality in these sites.
The strengths of our review include the systematic process
of identifying all studies that met our inclusion criteria,
using a structured literature search. The fact that the 25
studies identiﬁed were all limited to patients in ICUs and
did not include patients in obstetric high-dependency units
enabled us to make some meaningful comparisons and to
identify that the most widely used mortality prediction
model performs poorly in pregnant and recently pregnant
women from both HICs and LMICs. Limitations of our
study include the retrospective nature of the majority of
studies included and the differences in information
collected among studies, resulting in missing data and small
numbers for some comparisons. Comparisons among- JOGC - 2016 l 5
Table 3. Characteristics of women included in the review
Study
Maternal age
(y)
Primi-parous
(%) GA (wk)
Direct Indirect
HDP MOH Obs sepsis
DVT/PE/
AFE CVS Resp Endo CNS Infx
HIC
Single site
Lapinsky
et al.15
29.7 (mean) 30.9 (mean) 35.4 26.2 3.1 1.5 3.1 3.1 1.5
Afessa
et al.5
25.9 (mean) 29.2 (mean) 44.6 10.8 16.2 5.4 2.7 4.1 20.3
Heinonen
et al.13
28 (median) 50.0 39.5 (median) 32.0 73 18.0 22.0
Munnur
et al.22
26.1 (mean) 32.8 (mean) 62.1 29.3 27.6 1.1 2.3 6.3 2.9 0.6 17.8
Muench
et al.21
24.8 (median) 31 (median) 23.5 11.8 14.7 17.6 11.8 17.6 29.3
Multi-site
El Solh
et al.10
27.8 (mean) 28.7 (mean) 8.6 8.6 3.2 4.3 15.0 9.7 15.1 17.2
Mahutte
et al.18
31.0 (mean) 33.5 (mean) 21 34 14.0 10.0 10.0
Hazelgrove
et al.12
30 (median) 55.0 - 39.5 33.3 2.4 3.3 86.0 1.4 3.3
Lapinsky
et al.16
27.8 (mean) 31.2 (mean) 42.5 172 16
Harrison
et al.11
30.0 (median) - 38.2 32.8 2.7 1.7 0.8 1.4 1.5 3.2
Median
(IQR)
(HIC)
28.9 (27.4 to
30.3)
31.1 (29.6 to
33.3)
36.8 (22.9 to
43.0)
27.8 (11.6 to
33.5)
3.2 (2.7 to
16.2)
3.0 (1.3 to
5.1)
3.3 (1.5 to
14.7)
9.9 (3.6 to
17.9)
3.1 (2.2 to
8.0)
3.2 (1.3 to
15.7)
17.5 (4.9 to
21.6)
LMIC
Single site
Lewinsohn
et al.17
- - 15.5 31 24.1 10.3
Tang et al.25 31.6 (mean) 40.8 36.2 (mean) 14.3 53.1 2.0 10.2 2.0
Cheng and
Raman8
33.0 (mean) - 34.9 39.5 4.7 4.7 7.0
Demirkiran
et al.9
28.0 (mean) 34.7 (mean) 66.4 11.2 2.4 1.6 4.0 2.4 2.4 0.8
Mirghani
et al.19
32.5 (mean) 25 28.4 5.0 21.6 8.4
Munnur
et al.22
25.4 (mean) 54.8 30.6 (mean) 55.4 21 9.8 2.7 2.4 3.2 1.1 4.9 22.7
Continued
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Table 3.Continued
Study
Maternal age
(y)
Primi-parous
(%) GA (wk)
Direct Indirect
HDP MOH Obs sepsis
DVT/PE/
AFE CVS Resp Endo CNS Infx
Mjahed
et al.20
28.0 (mean) 35.0 (mean) 70.6 16.2 3.8 0.8 1.4 0.3 3.0 1.9
Vasquez
et al.26
28.0 (mean) 29.0 (mean) 40 26 16 1.0 4.0 1.0 3.0 10.0
Aldawood6 33.0 (mean) - 28 24.3 2.6 1.3 6.5 5.3 54.8
Bhadade
et al.7a
42.6 14.8 4 2.5 1.6 2.5 84.8
Wang
et al.28
41.7 23.8 10.9 6.9 5.0
Paternina-
Caicedo
et al.23
24.5 (mean) 30.2 34 (median) 45.7 23 5.5 1.2 4.3 11.2
Multi-site
Karnad
et al.14
25.5 (mean) 47.2 31 (mean) 55.8 21.9 6.2 1.5 0.4 38.6
Rios
et al.24
31.0 (mean) 39.7 71.7 12.7 5.7 1.9 1.4 1.4 7.5
Vasquez
et al.27a
30.0 (mean) 47.5 26.5 10.5 0.8 0.8 0.8 5.8
Median
(IQR)
(LMIC)
29.0 (26.1 to
32.3)
41.7 (37.3 to
49.1)
32.9 (30.7 to
34.9)
41.7 (25.0 to
55.8)
23.8 (16.2 to
28.4)
6.0 (4.0 to
10.8)
2.3 (1.4 to
4.8)
3.2 (1.3 to
6.5)
3.6 (1.1 to
7.9)
1.3 (1.0 to
3.1)
3.0 (2.2 to
4.2)
10.6 (4.8 to
42.7)
Median
(IQR) (all)
28.9 (27.4 to
31.2)
44.9 (40.0 to
53.6)
31.5 (30.7 to
34.5)
39.5 (24.3 to
51.5)
24.3 (14.5 to
31.9)
5.7 (3.1 to
16.0)
2.3 (1.4 to
4.8)
3.3 (1.4 to
10.2)
6.4 (2.1 to
10.2)
2.4 (1.1 to
4.1)
3.0 (2.0 to
4.2)
14.2 (5.2 to
24.4)
GA: gestational age; HDP: hypertensive disorder of pregnancy; MOH: major obstetric hemorrhage; Obs: obstetric; DVT: deep vein thrombosis; PE: pulmonary embolism; AFE: amniotic ﬂuid embolism; CVS:
cardiovascular system; Resp: respiratory; Endo: endocrine; CNS: central nervous system; Infx, infection; GA: gestational age; Obs: obstetric.
aProspective case series, all others retrospective.
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Table 4. Maternal and perinatal outcome and APACHE 2 results
Study Authors
Overall APACHE
II score
Predicted
maternal
mortality (%)
Observed
maternal
mortality (%) SMR
AUC ROC
APACHE II
Perinatal mortality
rate (%)
HIC
Single site
Lapinsky et al.15 6.8 (mean) - 0 - - 11.0
Afessa et al.5 14 (mean) 17.6 2.70 0.15 - 17.6
Heinonen et al.13 10.8 (mean) - 4.50 - - -
Munnur et al.22 10 (median) - 2.30 - - 13.0
Muench et al.21 11 (median) 12.9 - 0 - 8.8
Multi-site
El Solh et al.10 - 14.7 10.80 0.73 0.93 14.0
Mahutte et al.18 8.5 (mean) 10 2.30 0.23 - -
Hazelgrove et al.12 9 (median) 25 3.30 0.24 0.94 20.0
Lapinsky et al.16 16.8 (mean) 0.28 0.12 0.43 0.82 -
Harrison et al.11 10.9 (mean) 9.39 2.30 0.25 0.839 -
Median (IQR) (HIC) 10.8 (8.8 to 12.5) 12.9 (9.4 to 17.6) 2.5 (2.3 to 4.2) 0.24 (0.15 to 0.43) 0.885 (0.825 to 0.938) 13.5 (10.5 to 18.2)
LMIC
Single site
Lewinsohn et al.17 11 (mean) 16.6 6.90 0.42 - -
Tang et al.25 12.7 (mean) - - 0.22 - 10.0
Cheng and Raman8 7 (median) - 4.65 - - -
Demirkiran et al.9 - - 10.40 - - -
Mirghani et al.19 5 (mean) - 3.30 - - -
Munnur et al.22 16 (median) - 25.00 - - 51.0
Mjahed et al.20 12 (mean) 19.2 16.70 0.87 - 32.0
Vasquez et al.26 14 (mean) 24 11.00 0.46 - 32.0
Aldawood6 19.6 (mean) 21.97 8.00 0.36 - -
Bhadade et al.7a - 36.66 30.30 0.99 - -
Wang et al.28 9.7 (mean) 12.9 2.97 - - -
Paternina-Caicedo
et al.23
8 (median) 11.98 4.27 0.36 0.867 -
Multi-site
Karnad et al.14 16 (median) 26.7 21.60 0.78 - 52.0
Rios et al.24 6 (mean) - 2.50 - - 9.5
Vasquez et al.27a 8 (median) 7.6 3.6 0.47 0.886 17.0
Median (IQR) (LMIC) 11.0 (7.5 to 15.0) 19.2 (12.4 to 25.4) 7.5 (3.5 to 17.9) 0.46 (0.36 to 0.84) 0.877 (0.867 to 0.886) 32.0 (10.0 to 51.0)
Median (IQR) (all) 10.9 (8.0 to 14.0) 15.7 (10.5 to 23.5) 4.5 (2.5 to 10.8) 0.39 (0.23 to 0.67) 0.877 (0.834 to 0.933) 17.0 (10.5 to 32.0)
SMR: standardized mortality ratio; AUC ROC: receiver operating characteristic area under the curve.
aProspective case series, all others retrospective.
OBSTETRICSstudies may be limited due to differences in access to
health care and ICU admission criteria among sites and,
therefore, differences in disease severity. A further limita-
tion is the small number of cases in many of the studies
and the relatively low burden of maternal deaths. Because
raw numbers were not available, combining mean and
median values as estimates of central tendency from
studies was necessary for some of our statistical analyses.
Even though much has been published about pregnant and
recently pregnant women with severe morbidity admitted8 l - JOGC - 2016to ICUs, most are small observational studies. In an
overview of 30 published studies pertaining to obstetric
admission to the ICU, Zeeman identiﬁed (as we did) that
the hypertensive disorders of pregnancy and hemorrhage
were the two main indications for admission to the ICU.32
Zeeman also identiﬁed wide variations in death rates in the
published studies, ranging from 0% to 21%. However, the
critical care prediction models used in these studies were
not reviewed, whereas our review speciﬁcally assessed the
utility of the APACHE II score in pregnant and recently
pregnant women. In a systematic review by Pollock et al.,33
Figure. APACHE II-predicted versus observed mortality for
pregnant and recently pregnant women admitted to an ICU.
The gray zone represents under-prediction of maternal
mortality by APACHE II; the clear zone, overprediction. All
studies identiﬁed overprediction of maternal death by
APACHE II. Regression line slope: 0.75 (95% CI 0.41 to
1.09), y-intercept: L4.3 (95% CI L10.72 to 2.17)
The Usefulness of the APACHE II Score in Obstetric Critical Care: A Structured Reviewdifferences among studies conducted in HICs and LMICs
were assessed; the authors found no difference in the
incidence of indications for admission to the ICU between
countries but did ﬁnd a signiﬁcantly higher maternal
mortality rate in LMICs, as we have conﬁrmed. Equally,
there was a signiﬁcant difference in the severity of illness
scores reported, with a large mean difference in APACHE
II scores of 8.0 (P ¼ 0.01).33 This is a much larger dif-
ference than in our study; we found median APACHE II
scores of 10.8 in the HIC-based studies and 11.0 in the
LMIC-based studies (MWu P ¼ 0.987). Overall, 16 LMIC
studies and 25 HIC studies were included in the analysis of
Pollock et al., although the number of studies included in
determining the differences between APACHE II scores
was not speciﬁed.
We conclude that an accurate critical care prediction model
is required for maternity patients admitted to an ICU. Such
a model should account for maternal physiology and
should perform equally well in women from both HICs
and LMICs. Our hope is that the Collaborative Integrated
Pregnancy High-dependency Estimate of Risk (CIPHER)
model that is being developed and validated in multiple
international centres will satisfy these criteria.CONCLUSION
This is the largest structured review to date of the
performance of APACHE II in pregnant and recently
pregnant women receiving critical care. The use of the
APACHE II score to compare ﬁndings among studies may
assist in making standardized comparisons of results
among sites and studies and between countries for preg-
nant and recently pregnant women receiving critical care.
However, using the APACHE II score does not accurately
identify which pregnant or recently pregnant women
receiving critical care are at increased risk of mortality. We
hope that a new scoring model, currently under develop-
ment, will enable us to do so.ACKNOWLEDGEMENTS
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